SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: software salesperson who wrote (1637)6/12/2003 2:24:16 AM
From: Biotech Jim  Read Replies (2) | Respond to of 3044
 
My sources tell me that the metabolic diseases and cardiovascular groups will be largely downsized or cut out entirely in the refocused discovery effort at MLNM. Oncology and inflammation will be the discovery focus, FWIW.

BJ